| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -39.02M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ELDN returned +31.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +125.8% |
| 1 year | +31.2% |
| 5 years | -59.0% |
| 10 years | -98.1% |
| All-time high | $2,498.04 (Oct 2014) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ELDN would be worth today ›No. Eledon Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Eledon Pharmaceuticals, Inc. stock trades on NASDAQ under the ticker symbol ELDN.
Eledon Pharmaceuticals, Inc. is part of the Healthcare sector.
Eledon Pharmaceuticals, Inc. has a market cap of 277.10M USD, based on the latest quote.
Eledon Pharmaceuticals, Inc. is expected to report earnings around Nov 13, 2026. That date is an estimate and has not been confirmed by the company.
